Updated Jul 16, 2026
Davis Jennifer L. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.61M.
Jennifer L. Davis is the CEO of Health Care at Procter & Gamble, a leading consumer goods company. She has been involved in various roles within the company, contributing to its growth and innovation in the health care sector.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-12 | ABBV | AbbVie Inc. | A — Grant or award | 1.1K | $0.00 | |
| 2025-10-02 | PG | PROCTER GAMBLE Co | S — Open-market sale | 3.2K | $152.23 | $491K |
| 2025-08-19 | PG | PROCTER GAMBLE Co | S — Open-market sale | 8.6K | $157.27 | $1.35M |
| 2025-08-18 | PG | PROCTER GAMBLE Co | A — Grant or award | 21.5K | $0.00 | |
| 2024-12-20 | PG | PROCTER GAMBLE Co | F — Tax withholding / forfeiture | 46 | $169.79 | $8K |
| 2024-12-20 | PG | PROCTER GAMBLE Co | M — Option exercise | 46 | $169.79 | $8K |
| 2024-10-03 | PG | PROCTER GAMBLE Co | S — Open-market sale | 4.4K | $171.65 | $763K |
Jennifer L. Davis is the CEO of Health Care at Procter & Gamble, a leading consumer goods company. She has been involved in various roles within the company, contributing to its growth and innovation in the health care sector.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($2.61M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Davis Jennifer L. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.